Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Factor XI”

31 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 31 results

Not applicableUnknownNCT01538160
What this trial is testing

A Single and Low Dose of Recombinant Factor VIIa in Patients With Severe Factor XI Deficiency Undergoing Surgery

Who this might be right for
Hemophilia C
Sheba Medical Center 15
Large-scale testing (Phase 3)Looking for participantsNCT07213778
What this trial is testing

REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult Participants

Who this might be right for
Symptomatic Venous Thromboembolism (VTE)
Regeneron Pharmaceuticals 2,000
Not applicableNo Longer AvailableNCT01701947
What this trial is testing

HEMOLEVEN® Expanded Access Program Prevention of Surgical/Postpartum Hemorrhage Severe Inherited Factor XI Deficiency

Who this might be right for
Wound; Rupture, Surgery, Cesarean SectionPostpartum HemorrhageSurgery
Laboratoire français de Fractionnement et de Biotechnologies
Large-scale testing (Phase 3)Looking for participantsNCT07626411
What this trial is testing

Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation

Who this might be right for
Atrial Fibrillation (AF)
Regeneron Pharmaceuticals 15,364
Testing effectiveness (Phase 2)Study completedNCT05027074
What this trial is testing

Global Study of MK-2060 (Anti-Factor XI Monoclonal Antibody) in Participants With End Stage Renal Disease Receiving Hemodialysis (FXI Hemodialysis Study) (MK-2060-007)

Who this might be right for
End-Stage Renal DiseaseEnd-Stage Kidney DiseaseKidney Failure, Chronic
Merck Sharp & Dohme LLC 506
Early research (Phase 1)Study completedNCT02902679
What this trial is testing

Evaluate the Safety and Pharmacokinetics of BMS-986177 in Participants With End-stage Renal Dysfunction on Chronic Stable Hemodialysis Treatment

Who this might be right for
ThrombosisFactor XIRenal Impairment+1 more
Bristol-Myers Squibb 6
Testing effectiveness (Phase 2)Study completedNCT06299111
What this trial is testing

A Trial to Learn How Well REGN9933 and REGN7508 Work for Preventing Blood Clots, and How Safe They Are, in Adults Who Have a Peripherally Inserted Central Catheter (PICC)

Who this might be right for
Venous Thromboembolism
Regeneron Pharmaceuticals 195
Testing effectiveness (Phase 2)Active Not RecruitingNCT04755283
What this trial is testing

Safety and Tolerability of Abelacimab (MAA868) vs. Rivaroxaban in Patients With Atrial Fibrillation

Who this might be right for
Atrial Fibrillation (AF)Stroke
Anthos Therapeutics, Inc. 1,287
Early research (Phase 1)Looking for participantsNCT07430397
What this trial is testing

A Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CITY-FXI in Healthy Adults and Adults With FV Leiden or Prothrombin G20210A Mutation

Who this might be right for
Factor V LeidenProthrombin G20210A
City Therapeutics 128
Large-scale testing (Phase 3)Looking for participantsNCT07430956
What this trial is testing

Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable

Who this might be right for
Atrial Fibrillation (AF)
Regeneron Pharmaceuticals 2,628
Early research (Phase 1)Study completedNCT06444178
What this trial is testing

Assessment of Gastrointestinal Blood Loss After Receiving Aspirin or Aspirin Plus Rivaroxaban, or Aspirin Plus REGN9933, or Aspirin Plus REGN7508 in Healthy Adult Participants

Who this might be right for
Healthy Volunteers
Regeneron Pharmaceuticals 224
Not applicableUnknownNCT03347591
What this trial is testing

Rare Bleeding Disorders in the Netherlands

Who this might be right for
Rare Bleeding Disorders
Radboud University Medical Center 300
Testing effectiveness (Phase 2)WithdrawnNCT03398434
What this trial is testing

Efficacy and Safety of MAA868 in Patients With Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Novartis Pharmaceuticals
Early research (Phase 1)Not Yet RecruitingNCT07759167
What this trial is testing

Study of 3 Monoclonal Antibodies (REGN9933, REGN7508, and REGN9533) in Adult Participants With End-Stage Kidney Disease on Hemodialysis

Who this might be right for
End-Stage Kidney Disease (ESKD)
Regeneron Pharmaceuticals 36
Not applicableStudy completedNCT03165643
What this trial is testing

The DNA Methylation of ARHGEF11 in Macrosomia

Who this might be right for
Gestational DiabetesDiabetesMacrosomia, Fetal
Peking University First Hospital 239
Testing effectiveness (Phase 2)UnknownNCT04833764
What this trial is testing

Mechanisms of Deep Vein Thrombosis (DVT) and Vein Wall Fibrosis

Who this might be right for
Post-thrombotic SyndromeDeep Vein Thrombosis Leg
Khanh Nguyen 30
Early research (Phase 1)Study completedNCT05102136
What this trial is testing

Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of REGN9933 in Adult Healthy Volunteers

Who this might be right for
Healthy Volunteers
Regeneron Pharmaceuticals 56
Not applicableUnknownNCT02785718
What this trial is testing

The Proteins of the Contact Activation System

Who this might be right for
Factor XI DeficiencyFactor XII Deficiency
Hospices Civils de Lyon 18
Testing effectiveness (Phase 2)Active Not RecruitingNCT06180889
What this trial is testing

Factor XI inhibiTion for the Prevention of Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty

Who this might be right for
Knee Arthroplasty, Total
Suzhou Alphamab Co., Ltd. 241
Testing effectiveness (Phase 2)Study completedNCT06454630
What this trial is testing

A Trial to Learn How Well REGN7508 Works for Preventing Blood Clots After a Knee Replacement in Adult Participants

Who this might be right for
Venous Thromboembolism
Regeneron Pharmaceuticals 179
Next Page